Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

1. Martín-Gutiérrez, N.
2. Sánchez-Hernández, J.G.
3. Rebollo, N.
4. Pordomingo, A.F.
5. Muñoz, F.
6. Otero, M.J.